4//SEC Filing
Salmon Sean 4
Accession 0001613103-23-000097
CIK 0001613103other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 8:20 PM ET
Size
9.0 KB
Accession
0001613103-23-000097
Insider Transaction Report
Form 4
Salmon Sean
EVP & Group President Diabetes
Transactions
- Award
Ordinary Shares
2023-08-03+5,604→ 52,095 total - Tax Payment
Ordinary Shares
2023-08-03$84.49/sh−4,369$369,137→ 47,726 total - Exercise/Conversion
Performance Share Units
2023-08-03−5,604→ 0 total→ Performance Share Unit (5,604 underlying)
Footnotes (5)
- [F1]Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents.
- [F2]Includes 201 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1.
- [F3]Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023.
- [F4]Each performance share unit represented a contingent right to receive one share of Medtronic common stock.
- [F5]The performance share units vested on August 3, 2023.
Documents
Issuer
Medtronic plc
CIK 0001613103
Entity typeother
Related Parties
1- filerCIK 0001792380
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 8:20 PM ET
- Size
- 9.0 KB